Clovis Oncology Inc (CLVS) Insider Trading
- $762,459.50
- $33,451,209.12
- Oct. 3, 2022
- Gillian C Ivers-Read
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Nov. 15, 2017 | Insider | 3,000 | $63.70 | Sell | $191,100.00 | |
| Oct. 16, 2017 | Insider | 3,000 | $84.54 | Sell | $253,620.00 | |
| Sept. 15, 2017 | Insider | 3,000 | $69.50 | Sell | $208,500.00 | |
| Aug. 15, 2017 | Insider | 3,000 | $70.05 | Sell | $210,150.00 | |
| Aug. 4, 2017 | Director | 18,450 | $78.61 | Sell | $1,450,354.50 | |
| July 17, 2017 | Insider | 3,000 | $91.56 | Sell | $274,680.00 | |
| June 15, 2017 | Insider | 3,000 | $61.82 | Sell | $185,460.00 | |
| May 15, 2017 | Insider | 3,000 | $47.39 | Sell | $142,170.00 | |
| April 17, 2017 | Insider | 3,000 | $56.02 | Sell | $168,060.00 | |
| March 15, 2017 | Insider | 3,000 | $66.99 | Sell | $200,970.00 | |
| Nov. 2, 2015 | CFO | 3,000 | $105.56 | Sell | $316,680.00 | |
| Oct. 28, 2015 | insider | 4,000 | $98.02 | Sell | $392,080.00 | |
| Oct. 15, 2015 | Insider | 3,000 | $91.91 | Sell | $275,730.00 | |
| Oct. 5, 2015 | insider | 4,000 | $93.04 | Sell | $372,160.00 | |
| Oct. 1, 2015 | CFO | 3,000 | $90.22 | Sell | $270,660.00 | |
| Sept. 18, 2015 | Insider | 3,000 | $112.56 | Sell | $337,680.00 | |
| Sept. 1, 2015 | CFO | 3,000 | $79.51 | Sell | $238,530.00 | |
| July 1, 2015 | CFO | 3,000 | $85.70 | Sell | $257,100.00 | |
| June 1, 2015 | CFO | 3,000 | $88.78 | Sell | $266,340.00 | |
| May 15, 2015 | Director | 2,424 | $92.43 | Sell | $224,050.32 | |
| April 1, 2015 | CFO | 3,000 | $71.25 | Sell | $213,750.00 | |
| March 9, 2015 | CFO | 9,000 | $78.84 | Sell | $709,560.00 | |
| March 5, 2015 | Director | 8,528 | $77.70 | Sell | $662,625.60 | |
| Jan. 16, 2015 | Insider | 10,000 | $67.00 | Sell | $670,000.00 | |
| Dec. 11, 2013 | CFO | 50,000 | $52.78 | Sell | $2,639,000.00 | |
| Dec. 5, 2013 | Director | 9,000 | $56.10 | Sell | $504,900.00 | |
| June 5, 2013 | Insider | 22,594 | $68.54 | Sell | $1,548,592.76 | |
| June 4, 2013 | Insider | 10,000 | $73.06 | Sell | $730,600.00 | |
| June 4, 2013 | Major Shareholder | 159,192 | $64.58 | Sell | $10,280,619.36 | |
| June 4, 2013 | Director | 2,483 | $70.80 | Sell | $175,796.40 | |
| March 6, 2013 | Major Shareholder | 250,000 | $24.59 | Sell | $6,147,500.00 | |
| Aug. 16, 2012 | Director | 9,701 | $15.50 | Buy | $150,365.50 |
Insiders are both buying and selling Clovis Oncology Inc stock.
The insider traders at Clovis Oncology Inc are: Gillian C Ivers-Read, Lindsey Rolfe, Daniel W Muehl, Thorlef Spickschen, Thomas C Harding, Paul Edward Gross, Erle T Mast, James C Blair, Erle T. Mast, Parters Vii L P Domain, M James Barrett, Steven L Hoerter, Edward J Mckinley, Andrew R Allen, Erle Mast, Thomas C. Harding, and Patrick J Mahaffy
The most active insider trader at Clovis Oncology Inc is Gillian C Ivers-Read with 21 trades.
Parters Vii L P Domain has sold the most Clovis Oncology Inc stock with a total value of $26,708,738.72.
Patrick J Mahaffy has bought the most Clovis Oncology Inc stock with a total value of $559,000.00.
The most recent insider trade for Clovis Oncology Inc was on Oct. 3, 2022.
The single biggest insider buy for Clovis Oncology Inc was from Patrick J Mahaffy with a total value of $279,500.00 on Aug. 16, 2019.
The single biggest insider sell for Clovis Oncology Inc was from Parters Vii L P Domain with a total value of $10,280,619.36 on June 4, 2013.